WO2025158382 - VECTOR COMPOSITIONS FOR GUIDE NUCLEIC ACID DELIVERY AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/158382
Publication Date
31.07.2025
International Application No.
PCT/IB2025/050821
International Filing Date
24.01.2025
Title **
[English]
VECTOR COMPOSITIONS FOR GUIDE NUCLEIC ACID DELIVERY AND USES THEREOF
[French]
COMPOSITIONS VECTORIELLES POUR ADMINISTRATION D'ACIDES NUCLÉIQUES GUIDES ET UTILISATIONS ASSOCIÉES
Applicants **
COSYNE THERAPEUTICS LIMITED
Inventors
LUGINBUHL, Joachim
WATKINS, Rachel
Priority Data
63/625,846
26.01.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4886 | |
| EPO | Filing, Examination, Granting | 95010 | |
| Japan | Filing, Examination, Granting | 4834 | |
| South Korea | Filing, Examination, Granting | 7397 | |
| USA | Filing, Examination, Granting | 31540 |
Total:
143,667
Contact Us
Abstract[English]
Provided herein are compositions for delivering a guide nucleic acid and/or a gene editing system to a cell. Various vectors, promoters, guide nucleic acid sequences, self-cleaving peptide sequences, and regulatory elements are disclosed. Methods, compositions, and kits provided herein can be used as biotechnology tools for analyzing genetic interactions, cell phenotyping, single cell genomics, and to deliver guides for gene editing system assays.[French]
L'invention concerne des compositions pour administrer un acide nucléique guide et/ou un système d'édition génique à une cellule. Divers vecteurs, promoteurs, séquences d'acides nucléiques guides, séquences peptidiques à auto-clivage et éléments régulateurs sont divulgués. Les procédés, les compositions et les kits selon l'invention peuvent être utilisés en tant qu'outils de biotechnologie pour analyser des interactions génétiques, le phénotypage cellulaire, la génomique unicellulaire et pour délivrer des guides pour des dosages de système d'édition génique.